TenderAi Logo

Discover the latest tenders, get AI-powered insights, and collaborate to seize government opportunities with TenderAI.

Contact Us

✉️ contact@tenderai.in📞 +91-8448770364

Departments

View All
Department of Military Affairs(90827)
Department of Defence Production(20910)
Indian Railways(14280)
Department of Heavy Industry(10115)
Department of Atomic Energy(10071)

States

View All
MAHARASHTRA(20071)
UTTAR PRADESH(18984)
JAMMU & KASHMIR(12651)
GUJARAT(11830)
KARNATAKA(9749)

Cities

View All
MUMBAI(6104)
BANGALORE(5435)
HYDERABAD(3403)
PUNE(3272)
JAMMU(2591)
Privacy Policy|Terms of Service

© 2025 TenderAI. All rights reserved.

bracing lifesciences private limited Tender Performance & Track Record

CIN: U24299UP2016PTC084416
Active
Private
Company limited by shares

bracing lifesciences private limited

Tender Performance & Track Record

CIN: U24299UP2016PTC084416
Active
Private
Company limited by shares

Company Overview

Summary
Government Tender Analysis: Bracing Lifesciences Private Limited Bracing Lifesciences Private Limited, a key player in the pharmaceutical sector, demonstrates active participation in Indian government tenders. As an established pharmaceutical supplier and healthcare provider, this report provides a comprehensive analysis of Bracing Lifesciences’ tender performance, financial health, and competitive landscape, specifically relevant to Indian government procurement.
Primary Ministry: Ministry of RailwaysPrimary Department: Indian Railways
Founded: 2016State: UTTAR PRADESH
Primary Ministry:
Ministry of Railways
Primary Department:
Indian Railways
Founded:2016
State:UTTAR PRADESH

Tender Performance

Data for 01 April 2024 to 18 June 2025

Live Data

Total Bids / Contract Value

Bids11
Value₹2.09Cr

Qualified Bids / Q Rate

Bids7
Q Rate63.6%

Total Wins / Win Value

Win6
Value₹1.83Cr

Wins Rate / Q-W Rate

Rate54.5%
Q-W Rate85.7%

Detailed Performance Analysis

Scroll to view more categories

Tender Performance by Ministries

3 entries

Name

Bids
Value
Qualified
Wins
Value

Ministry of Railways

33.3% win rate
6
₹4.84 Lakh
2
2
₹57K

Ministry of Railways

Bids
6
₹4.84 Lakh
Qualified
2
Wins
2
₹57K
33.3% win rate

Ministry of Health and Family Welfare

100.0% win rate
2
₹21.64 Lakh
2
2
₹21.64 Lakh

Ministry of Health and Family Welfare

Bids
2
₹21.64 Lakh
Qualified
2
Wins
2
₹21.64 Lakh
100.0% win rate

Ministry of Defence

100.0% win rate
1
₹2.39 Lakh
1
1
₹2.39 Lakh

Ministry of Defence

Bids
1
₹2.39 Lakh
Qualified
1
Wins
1
₹2.39 Lakh
100.0% win rate

Top Bid Competitors

Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 11 bids — CAREWELL INDIA appeared in 5 of them.

Company
Total Bids
Value
Qualified
Rate
Wins
Value

BRACING LIFESCIENCES PRIVATE LIMITED

Your Company
54.5% win rate
11
₹2.09 Cr
7
63.6%
6
₹1.83 Cr

BRACING LIFESCIENCES PRIVATE LIMITED

Your Company
Total Bids
11
₹2.09 Cr
Qualified
7
63.6%
Wins
6
₹1.83 Cr
54.5% win rate
CAREWELL INDIA
40.0% win rate
5
₹4.60 Lakh
3
60.0%
2
₹3.71 Lakh
CAREWELL INDIA
Total Bids
5
₹4.60 Lakh
Qualified
3
60.0%
Wins
2
₹3.71 Lakh
40.0% win rate
AVIENCE BIOMEDICALS PRIVATE LIMITED
33.3% win rate
3
₹1.16 Lakh
1
33.3%
1
₹23K
AVIENCE BIOMEDICALS PRIVATE LIMITED
Total Bids
3
₹1.16 Lakh
Qualified
1
33.3%
Wins
1
₹23K
33.3% win rate
LORD'S MARK INDUSTRIES LIMITED
0.0% win rate
3
₹2.95 Lakh
0
0.0%
0
₹0
LORD'S MARK INDUSTRIES LIMITED
Total Bids
3
₹2.95 Lakh
Qualified
0
0.0%
Wins
0
₹0
0.0% win rate
AFFIGENIX BIOSOLUTIONS PRIVATE LIMITED
0.0% win rate
3
₹1.16 Lakh
0
0.0%
0
₹0
AFFIGENIX BIOSOLUTIONS PRIVATE LIMITED
Total Bids
3
₹1.16 Lakh
Qualified
0
0.0%
Wins
0
₹0
0.0% win rate
BIOSCI HEALTH CARE
0.0% win rate
2
₹92K
0
0.0%
0
₹0
BIOSCI HEALTH CARE
Total Bids
2
₹92K
Qualified
0
0.0%
Wins
0
₹0
0.0% win rate
ROYAL BIOTECH
0.0% win rate
2
₹56K
0
0.0%
0
₹0
ROYAL BIOTECH
Total Bids
2
₹56K
Qualified
0
0.0%
Wins
0
₹0
0.0% win rate
MERIL DIAGNOSTICS PRIVATE LIMITED
0.0% win rate
2
₹1.58 Cr
0
0.0%
0
₹0
MERIL DIAGNOSTICS PRIVATE LIMITED
Total Bids
2
₹1.58 Cr
Qualified
0
0.0%
Wins
0
₹0
0.0% win rate
NUCLEUS DIAGNOSYS LLP
0.0% win rate
2
₹83K
0
0.0%
0
₹0
NUCLEUS DIAGNOSYS LLP
Total Bids
2
₹83K
Qualified
0
0.0%
Wins
0
₹0
0.0% win rate
BIOGENIX INC. PRIVATE LIMITED
0.0% win rate
1
₹22.54 Lakh
1
100.0%
0
₹0
BIOGENIX INC. PRIVATE LIMITED
Total Bids
1
₹22.54 Lakh
Qualified
1
100.0%
Wins
0
₹0
0.0% win rate
MICROLAB INSTRUMENTS PRIVATE LIMITED
0.0% win rate
1
₹2.39 Lakh
0
0.0%
0
₹0
MICROLAB INSTRUMENTS PRIVATE LIMITED
Total Bids
1
₹2.39 Lakh
Qualified
0
0.0%
Wins
0
₹0
0.0% win rate
Company Profile
CINU24299UP2016PTC084416
Class
Private
Status
Active
Founded2016

Financial Details

Authorized Capital₹10.0L
Paid-up Capital₹10.0L

Registered Office

409, SARASWATI PURAM BICHIANA-GORAKHPUR-Uttar Pradesh-273014-India


Industry Classification

Manufacturing (Metals & Chemicals, and products thereof)

NIC Code24299

Company Type

CategoryCompany limited by shares
Sub-CategoryNon-government company
Origin
Indian

Market Information

Listing Status
Unlisted
ROCROC Kanpur
Free Trial!

Transform Your Tender Process

Join thousands of businesses winning more tenders

No Credit Card Required
0%
Success Rate
0x
Faster Process
0/7
24/7 Support

Smart Alerts

Get AI-powered tender recommendations

Market Intel

Track competitor bidding patterns

Email Reports

Weekly detailed analytics reports

Download Hub

Export tender data in bulk format

Smart Tracking

Never miss important deadlines

& Much More...

Discover all premium features with your trial

DS

"TenderAI transformed our bidding process. We've increased our win rate by 40% and saved countless hours."

Dipanshu Sahijpal • Supernirman
Start 15-Day Free Trial
Secure & Trusted
24/7 Support
Easy Setup

Historical Performance

7-year trend analysis (2018-2025)

Historical Data

Company Overview (1 Apr 2018-31 Mar 2025))

Total Bids

47

Qualified: 22
Q Rate: 46.8%

Contract Value

₹77.56 Lakh

Avg. Bid: ₹4.36 Lakh
Avg. EMD: ₹0

L1 Bids

9

Win Rate: 19.1%
Q to W Ratio: 40.9%

Recent Win Rate

42.9%

Change: +20.6%
Period: FY 2024-25

Performance Analytics

Last 7 Years
Performance Trend
Win/Loss Distribution
Contract Value Growth Over Time

Government Tender Analysis: Bracing Lifesciences Private Limited

Bracing Lifesciences Private Limited, a key player in the pharmaceutical sector, demonstrates active participation in Indian government tenders. As an established pharmaceutical supplier and healthcare provider, this report provides a comprehensive analysis of Bracing Lifesciences’ tender performance, financial health, and competitive landscape, specifically relevant to Indian government procurement.

Executive Summary

Bracing Lifesciences has submitted 47 bids for government tenders, securing a win rate of 19.1% and demonstrating their presence in the public procurement sector. In FY2024-25, the company achieved a 42.9% win rate, marking a significant improvement. Between April 2018 and March 2025, they have qualified in 22 tenders, showcasing a qualification rate of 46.8%. The company's engagement with the Ministry of Railways, Ministry of Health and Family Welfare, and other key departments highlights their focused procurement strategy. Their financial health is rated as 'Concerning' with a score of 49.9/100, indicating areas for improvement despite recent growth. Key performance metrics include a 137.3% growth in total contract value in FY2024-25 compared to FY2023-24, reflecting increased success in securing higher-value contracts. This analysis is designed for Indian government procurement officers and industry stakeholders to assess Bracing Lifesciences as a potential vendor or partner.

Financial Performance Analysis

Bracing Lifesciences's financial performance shows a dynamic trend over the past several fiscal years. The analysis includes yearly trends, quarterly patterns, and bid distribution to provide a complete financial overview.

Yearly Trends:

A comparative table highlights year-on-year performance from FY2018-19 to FY2024-25. FY2024-25 shows the highest win rate at 42.9% and a total contract value of ₹47,72,783. In contrast, FY2019-20 and FY2020-21 had no bids, indicating a period of inactivity. The growth in contract value from ₹8,22,007 in FY2022-23 to ₹20,11,141 in FY2023-24, and further to ₹47,72,783 in FY2024-25, demonstrates a strong upward trajectory.